Clinical Trials Logo

Filter by:
NCT ID: NCT03551301 Completed - Clinical trials for Substance Use Disorders

Transitional Case Management for Patients Suffering From Substance Use Disorders

Start date: September 1, 2017
Phase:
Study type: Observational

According to the World Health Organization the population suffering from addiction problems is increasing. This population is characterized by multiple needs at the medico-psychosocial level. However, some of these patients, a particular subgroup that we are going to be interested in the so-called "high need" user group, find it difficult to access and stay in outpatient treatment programs. They often present a chaotic use of the health system, including a high number of hospitalizations in times of crisis. They also show very low utilization of health care services, accompanied by social marginalization. This can be related to relapses and poor social functioning. A high number of relapses occur particularly at the end of hospitalization. Interventions in the field of addiction, such as Transitional Case Management (TCM) should increase the adherence of these patients to treatment by accompanying them in the sensitive period following hospitalization. One of the objectives of the study is to evaluate the impact of TCM on the number, duration and type of hospitalizations, as well as the number of emergency room visits. The investigators will also measure the duration until the possible future hospitalization, after the TCM. The secondary objectives of this study will be to see the effect of TCM on adherence to outpatient treatment. The investigators will focus on the impact of follow-up on the participant's medico-psycho-social network, substance use and other psychological variables. The investigators will also evaluate his or her psychiatric symptoms and global and social functioning. Life satisfaction and satisfaction with the care received will also be measured. The investigators will compare the population treated by the TCM with the other users of the addiction service who are hospitalized. The study will investigate this through questionnaires at the beginning of care, at one month, three months, six months and 12 months after the start of TCM management.

NCT ID: NCT03551106 Completed - Learning Clinical Trials

E-learning Module to Improve Laboratory Prescriptions

CLAB1
Start date: June 1, 2018
Phase:
Study type: Observational

Objective: To evaluate the effectiveness of a web based learning module in the prescription of laboratory examens by postgraduate medical students. Background: The internal medicine service of Valais encounters several prescription issues such as overprescription of blood iron or transferrin level determination and too rare D vitamine level. Methods: The investigators will introduce postgraduate medical students to a single use e-learning module about common deficiencies in hospitalized patients. A quick test will be performed before and after the module, then at 2 and 4 months. Efficiency will be determined by the analysis of the median number of prescriptions of blood iron, transferrin and D vitamine levels 6 months before the module then monthly until completion of the study . It is planned to recruit between 40 and 55 students. Outcome: The investigators will evaluate efficiency of the web based learning module by analysing the prescription rate 5 months before and 5 months after the intervention. Second outcome will be testing of the efficiency over time by monthly analysis of the prescriptions and results at the test.

NCT ID: NCT03548987 Completed - Obesity Clinical Trials

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

STEP 4
Start date: June 4, 2018
Phase: Phase 3
Study type: Interventional

This study will look at the change in participant's body weight from the start to the end of the study. This is to compare the effect on body weight in people taking semaglutide (a new medicine) and people taking "dummy" medicine. In addition to taking the medicine, the participant will have talks with study staff about healthy food choices, how to be more physically active and what a participant can do to lose weight. The participant will get semaglutide for the first 20 weeks. Then the participant will get either semaglutide or "dummy" medicine - which treatment the participant gets after the 20 weeks is decided by chance. The participants will need to take 1 injection once a week. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The study will last for about 1.5 years.

NCT ID: NCT03548220 Completed - Clinical trials for Pyruvate Kinase Deficiency

A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

Start date: August 9, 2018
Phase: Phase 3
Study type: Interventional

Study AG348-C-006 evaluated the efficacy and safety of orally administered AG-348 as compared with placebo in participants with pyruvate kinase (PK) deficiency, who were not regularly receiving blood transfusions. Participants were randomized 1:1 to receive either AG-348 or a matching placebo.

NCT ID: NCT03547947 Recruiting - Avascular Necrosis Clinical Trials

Clinical and Radiological Outcomes of Medacta Shoulder System

Start date: June 13, 2018
Phase:
Study type: Observational

This is a post-marketing surveillance on Medacta Shoulder System

NCT ID: NCT03547674 Completed - Cerebral Palsy Clinical Trials

Tuned Versus Untuned Ankle-foot Orthoses in Children and Adolescents With Cerebral Palsy

AFO
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Cerebral palsy (CP) in children and adolescents is frequently accompanied by gait abnormalities. Ankle-foot orthoses (AFO) have been suggested to improve the gait pattern. Compared to conventional AFO, modular AFO offer the opportunity to tune its response to the patient's gait characteristics and/or functional maturity. However, the evidence level is still small and AFO tuning is not yet established in clinical routine. The study will investigate individual tuning of custom-built ankle-foot-orthoses (AFO) using gait analyses

NCT ID: NCT03547661 Completed - Clinical trials for Premenstrual Syndrome

Open-Label Placebo Treatment of Women With Premenstrual Syndrome

OLPPMS_1
Start date: August 2, 2018
Phase: N/A
Study type: Interventional

This study aims to investigate the effect of an open-label placebo intervention on premenstrual syndrome (PMS) complaints. Women who suffer from moderate to severe PMS will be randomly allocated to three groups: to a treatment as usual group, an open-label placebo group, and an integrative open-label placebo group. Participants of all groups will conclude a prospective PMS screening for one menstrual cycle. Thereafter, participants of both intervention groups will obtain an openly administered placebo intervention for six weeks. Participants of the treatment as usual group will have the chance to obtain the same open-label placebo intervention after study conduct. Diverse measures will be assessed by means of a PMS symptom diary and questionnaires. Furthermore, we assess participants experiences of study participation qualitatively by means of semi-structured interviews.

NCT ID: NCT03545568 Completed - Clinical trials for N-Acetylneuraminic Acid Storage Disease

Sialic Acid Supplementation in N-Acetylneuraminic Acid Synthase (NANS) Deficiency

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

This study is aimed at assessing the impact of short-term (3 days) exogenous sialic acid supplementation on endogenous biomarkers of sialic acid metabolism in NANS deficient patients.

NCT ID: NCT03545334 Completed - Malignant Melanoma Clinical Trials

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study

LIMIT
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

A diagnostic sensitivity study comparing intradermal indocyanine green (ICG) and near infrared fluorescence imaging (NIRFI) with intradermal technetium 99m and traditional lymphoscintigraphy (LS) for transcutaneous identification of sentinel lymph nodes (SLN) in malignant melanoma - a prospective Phase II clinical study in a single center.

NCT ID: NCT03545191 Completed - Insomnia Disorder Clinical Trials

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

Start date: June 4, 2018
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to assess efficacy and safety of ACT-541468 (daridorexant) in adult and elderly subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.